ABCC1 and acute myeloid leukemia: To test this hypothesis, we first examined the correlation between the basal level of MRP1 and the cellular sensitivity to DNA alkylating agents of PEER (T-cell leukemia), Daudi (B-cell lymphoma) and MV4-11 (AML) cell lines.